icon-folder.gif   Conference Reports for NATAP  
 
  66th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 13-17 2015
Back grey_arrow_rt.gif
 
 
 
Baseline HCV NS5A Resistance-Associated Variants Do Not Impact SVR12 Rates in Non-Cirrhotic and Post-Liver Transplant Patients With Genotype 1 Infection Treated With Daclatasvir and Sofosbuvir With or Without Ribavirin for 12 Weeks: An Integrated Analysis
 
 
  Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco, CA
 
McPhee F,1 Hernandez D,1 Zhou N,1 Ueland J,1 Vellucci V,1 Hartman-Neumann S,1 Yang X,1 Han Z,1 Yu F,1 Yang R,2 Noviello S2
 
1Bristol-Myers Squibb Research and Development, Wallingford, CT; 2Bristol-Myers Squibb Research and Development, Princeton, NJ

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif

AASLD13.gif